Tuesday partnership
•
0 likes•1,137 views
Tuesday Vision Session: The Partnership at Drugfree.org: The Medicine Abuse Project - Free Tools to Educate Your Community About Teen Medicine Abuse
Report
Share
Report
Share
Download to read offline
Recommended
Tracy Kirby, Batten Disease Support and Research Foundation
The document discusses the role of the Batten Disease Support and Research Association (BDSRA) in supporting research for Batten disease. [1] Batten disease is a rare and fatal childhood neurological disorder. [2] BDSRA funds research, builds relationships between researchers and industry, and ensures the patient voice is heard throughout the drug development process from discovery to post-marketing. [3] BDSRA educates families, advocates for clinical trials, and disseminates information to help advance treatments for Batten disease.
Ch05
This document discusses health professional associations and how they balance professional and business objectives through strategic communication. It identifies the main functions of medical associations, which include advocating for members, communicating scientific knowledge, and marketing services to members. The document also stresses the importance of strategic communication planning and using various communication tools and channels to achieve organizational goals.
Ch07
This chapter discusses crisis communication in the health sector. It defines a health crisis as a significant disruption that receives extensive media coverage and impacts normal operations. A health crisis can be caused by natural disasters, criminal acts, or competition. The chapter outlines how to prepare for a crisis through developing a response plan, preventing crises, understanding organizational culture, and designating media spokespeople. During a crisis, communicators must be involved in decision making. Effective crisis communication focuses on solving problems, using effective spokespeople, controlling the media narrative, being transparent, and communicating internally and externally.
Ch012
The document discusses a public awareness campaign called The Heart Truth/Red Dress campaign launched by the National Heart, Lung, and Blood Institute in 2001 to educate women about heart disease risks. It summarizes how the campaign was born out of collaboration between government health experts and nonprofit advocacy groups like WomenHeart. The campaign featured women champions in red dresses to raise awareness that heart disease impacts all women. The document argues that the public-private partnership between government agencies, nonprofits, and corporations maximized the campaign's impact on increasing awareness about women's heart health risks.
Caring in America: A Guide to America’s Home Care Workforce
This document summarizes key facts about the home care workforce in the United States. It notes that there are over 2.5 million home care workers, who perform tasks related to self-care, everyday tasks, social support, and medical care. Home care work is among the fastest growing jobs and adds many new positions. Most home care workers are female, older, non-white, and have a high school education or less. They are employed by home care agencies or work directly for families. The home care industry is growing, but wages for home care workers are low and stagnant, many workers have part-time hours, and turnover is high due to low pay and few hours.
Climate Change - Van Vleet
This document discusses climate change and its impacts on public health from the perspective of the American Lung Association. It outlines the Association's mission to improve lung health and prevent lung disease. It then summarizes the health effects of air pollution and climate change, including increased risks from ozone, wildfires, allergens and extreme weather. The document urges health professionals to educate themselves on these issues, support policies to address climate change and air pollution, and speak out through op-eds, interviews or other advocacy.
Peter Lubambi: Reducing Maternal Mortality with mHealth, MobileMonday Dar es ...
Peter Lubambi from D-Tree International presented their initial finding and experiences on a mobile app designed to reduce maternal mortality.
Presentation available in YouTube:
http://www.youtube.com/watch?v=MWbEZ_HtlrA
Advocacy for preventive care umhb
Advocacy involves influencing outcomes for vulnerable groups, bringing about social justice, and empowering others. The document outlines how health care professionals can advocate for key issues like access to care, prevention of diseases and injuries, and removal of barriers facing at-risk populations. Advocacy occurs through direct contact with legislators, involvement in professional organizations, and collaboration with other advocacy groups at local, state, national and international levels to impact legislative processes and public health policies through respectful civic engagement.
Recommended
Tracy Kirby, Batten Disease Support and Research Foundation
The document discusses the role of the Batten Disease Support and Research Association (BDSRA) in supporting research for Batten disease. [1] Batten disease is a rare and fatal childhood neurological disorder. [2] BDSRA funds research, builds relationships between researchers and industry, and ensures the patient voice is heard throughout the drug development process from discovery to post-marketing. [3] BDSRA educates families, advocates for clinical trials, and disseminates information to help advance treatments for Batten disease.
Ch05
This document discusses health professional associations and how they balance professional and business objectives through strategic communication. It identifies the main functions of medical associations, which include advocating for members, communicating scientific knowledge, and marketing services to members. The document also stresses the importance of strategic communication planning and using various communication tools and channels to achieve organizational goals.
Ch07
This chapter discusses crisis communication in the health sector. It defines a health crisis as a significant disruption that receives extensive media coverage and impacts normal operations. A health crisis can be caused by natural disasters, criminal acts, or competition. The chapter outlines how to prepare for a crisis through developing a response plan, preventing crises, understanding organizational culture, and designating media spokespeople. During a crisis, communicators must be involved in decision making. Effective crisis communication focuses on solving problems, using effective spokespeople, controlling the media narrative, being transparent, and communicating internally and externally.
Ch012
The document discusses a public awareness campaign called The Heart Truth/Red Dress campaign launched by the National Heart, Lung, and Blood Institute in 2001 to educate women about heart disease risks. It summarizes how the campaign was born out of collaboration between government health experts and nonprofit advocacy groups like WomenHeart. The campaign featured women champions in red dresses to raise awareness that heart disease impacts all women. The document argues that the public-private partnership between government agencies, nonprofits, and corporations maximized the campaign's impact on increasing awareness about women's heart health risks.
Caring in America: A Guide to America’s Home Care Workforce
This document summarizes key facts about the home care workforce in the United States. It notes that there are over 2.5 million home care workers, who perform tasks related to self-care, everyday tasks, social support, and medical care. Home care work is among the fastest growing jobs and adds many new positions. Most home care workers are female, older, non-white, and have a high school education or less. They are employed by home care agencies or work directly for families. The home care industry is growing, but wages for home care workers are low and stagnant, many workers have part-time hours, and turnover is high due to low pay and few hours.
Climate Change - Van Vleet
This document discusses climate change and its impacts on public health from the perspective of the American Lung Association. It outlines the Association's mission to improve lung health and prevent lung disease. It then summarizes the health effects of air pollution and climate change, including increased risks from ozone, wildfires, allergens and extreme weather. The document urges health professionals to educate themselves on these issues, support policies to address climate change and air pollution, and speak out through op-eds, interviews or other advocacy.
Peter Lubambi: Reducing Maternal Mortality with mHealth, MobileMonday Dar es ...
Peter Lubambi from D-Tree International presented their initial finding and experiences on a mobile app designed to reduce maternal mortality.
Presentation available in YouTube:
http://www.youtube.com/watch?v=MWbEZ_HtlrA
Advocacy for preventive care umhb
Advocacy involves influencing outcomes for vulnerable groups, bringing about social justice, and empowering others. The document outlines how health care professionals can advocate for key issues like access to care, prevention of diseases and injuries, and removal of barriers facing at-risk populations. Advocacy occurs through direct contact with legislators, involvement in professional organizations, and collaboration with other advocacy groups at local, state, national and international levels to impact legislative processes and public health policies through respectful civic engagement.
Tue vs ameritox -yasko-brasika_de_george
This document discusses the history and current state of medical marijuana in the United States. It provides background on marijuana's medical use in the early 20th century and subsequent criminalization. Today, over half of Americans support legalization and 21 states have legalized medical marijuana, though it remains illegal at the federal level. The document outlines administration methods, potential medical benefits seen with certain conditions, and the need for more robust research studies. It also discusses the conflict between state and federal law on marijuana and analyzes trends in marijuana use and perceived risk among the public.
Tue vs ondcp spitznas
Tuesday Vision Session: Office of National Drug Control Policy (ONDCP): Solutions Discussion Impacting Neonatal Abstinence Syndrome
Leonard Young CORRECT
This document summarizes a study evaluating the impact of unsolicited reports on prescription drug use. The study compared individuals who received unsolicited reports about questionable prescription patterns to a matched comparison group. It found reductions in several measures of questionable drug use were greater for the unsolicited report group compared to the comparison group, including a statistically significant decline in number of pharmacies visited. However, limitations included difficulty finding a suitable comparison group and incomplete prescription records. Possible next steps proposed expanding the study to address limitations.
Peter Kreiner
The document summarizes research analyzing associations between opioid overdose rates and rates of questionable prescription activity in Massachusetts communities. Key findings include:
1. Rates of opioid overdoses were positively associated with population density, poverty rates, and rates of questionable prescription activity in communities after controlling for other socioeconomic factors.
2. Rates of questionable prescription activity predicted subsequent increases in opioid overdose rates in communities over time, even after accounting for initial overdose rates and socioeconomic characteristics.
3. This research provides some of the first evidence that prescription drug monitoring program measures of questionable activity are useful indicators of geographic areas facing higher risks of opioid overdose.
Tue vs samhsa - harding
Tuesday Vision Session: Substance Abuse and Mental Health Services Administration (SAMHSA): Examining Prescription Drug Misuse and Abuse from Federal and National Perspectives
Tuesday astho
The document summarizes a vision session on prescription opioid overdose that included presentations from the Oklahoma Commissioner of Health and the president of ASTHO. Key points discussed include:
- The growing epidemic of prescription opioid overdose deaths and costs to the healthcare system.
- ASTHO's Prescription Drug Overdose Prevention Challenge which aims to reduce overdose rates and engages state health officials and partners across sectors.
- Strategies discussed to address the epidemic through prevention, monitoring, enforcement, treatment and recovery efforts.
Tue vs centpatico - van tassell
This document discusses trauma and its impacts on children in foster care. It provides an overview of PTSD and high rates of PTSD among children in foster care due to abuse, neglect, and family dysfunction. It also discusses the overuse of psychotropic medications in foster care and the need for trauma-informed treatment. Non-pharmacological interventions like TF-CBT are effective for treating trauma in children. Trauma-informed approaches are also needed within the criminal justice system given high rates of trauma among justice-involved individuals.
Tue gs mc cance-katz
This document discusses the importance of treatment for opioid use disorders. It notes the rise in prescription pain medication abuse and related harms like overdoses. Treatment options like medication-assisted treatment with drugs like methadone and buprenorphine combined with counseling can effectively treat opioid addiction, improving health and social outcomes. The Substance Abuse and Mental Health Services Administration promotes such evidence-based treatment approaches and prevention efforts to address the prescription drug abuse epidemic.
Tue gs botticelli
This document summarizes the national perspective on prescription drug abuse in the United States. It outlines the federal government's Prescription Drug Abuse Prevention Plan, which takes a coordinated approach across four focus areas: education, prescription drug monitoring programs, proper medication disposal, and enforcement. The document also provides some statistics showing signs of progress in reducing prescription drug abuse, such as decreases in the number of Americans initiating nonmedical use of prescription opioids and in the rates of past year use among high school seniors of certain opioids. However, it notes that long-term success will require ongoing coordination across government levels.
Ph 4 rannizzisi
The document discusses the growing problem of prescription drug abuse and overdose deaths in the United States. Some key points made include:
- In 2010, there were over 38,000 drug overdose deaths in the US, with prescription drugs accounting for over 22,000 of those deaths.
- Prescription drug abuse is the fastest growing drug problem in the country.
- Deaths from drug overdoses now outnumber deaths from motor vehicle accidents.
- The number of forensic drug cases tested has increased over 240% from 2001 to 2011.
- States in the Southwest and Appalachia have the highest rates of drug overdose mortality.
Tue gs collins
This document summarizes NIH efforts to advance pain relief while curbing opioid abuse. It discusses research on abuse-deterrent drug formulations, easier-to-use naloxone delivery methods, digital interventions to prevent overdose, and vaccine development to treat addiction. Monitoring the Future study results on nonmedical prescription opioid and heroin use among youth are presented. The director highlights collaborative work on an oral oxycodone prodrug and a promising heroin vaccine in development.
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
This document outlines an advocacy track presentation on activating communities to address prescription drug abuse. It provides biographies of the presenters and moderators and discloses any conflicts of interest. The learning objectives are to identify best practices for implementing CADCA's seven strategies for community change to impact prescription drug issues. It then provides examples of how various coalitions across the country are utilizing each of the seven strategies, such as providing education, enhancing skills, supporting communities, and changing policies.
Be aware, take action: fight counterfeits, keep patients safer
The document summarizes initiatives to combat counterfeit medicines in various countries. It finds that healthcare professionals' roles are often unclear and they are not always at the forefront of counterfeiting issues. The WHPA campaign aims to strengthen advocacy for investing in healthcare professionals' education and capacity to detect, report, and prevent counterfeits. It establishes dialogue between stakeholders to share knowledge and resources and initiate cost-effective solutions. The WHPA Call to Action and toolkit provide strategies and resources to build comprehensive regional plans against counterfeiting through increasing professional capacity, regional cooperation, collaborative practice, and improved collaboration with authorities.
Rx16 heroin wed_330_1_rader_2lynch-earle
This document summarizes presentations from two communities - Huntington, WV and Camden County, NJ - on their responses to heroin crises. It outlines programs implemented in Huntington, including a harm reduction program, centralized information system, and drug court expansion. It also discusses the region's history with prescription drug abuse and rise in heroin and associated issues like hepatitis and neonatal abstinence syndrome. Long-term strategies proposed include expanding treatment services, promoting career opportunities for those in recovery, and preventing relapse through environmental design changes.
Rx16 advocacy wed_200_1_mendell_2manlove
This document provides information about an advocacy track presentation on advocating for change related to addiction issues. The presentation features Gary Mendell, founder and CEO of Shatterproof, and Kim Manlove from the Indiana Addictions Issues Coalition. They will discuss strategies for influencing legislation and how people in recovery can become advocates. The learning objectives focus on advocating for state laws on PDMP usage, explaining strategies to influence legislation, describing how people in recovery can advocate, and providing counsel as part of a treatment team. The presentation then provides details on Shatterproof's story, the overdose epidemic, solutions for different populations, and legislative accomplishments in various states related to expanding access to naloxone and mandating PDMP usage.
Moving Beyond Stigma
The William James College Forum, "Moving Beyond Stigma," took place on May 23, 2017 at the Back Bay Events Center, Boston. The all-day event drew over 450 attendees: policymakers, business men/women, clinicians, and families.
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
The document summarizes a presentation on collaboration, coordination, and data to address prescription drug abuse at the state level. It discusses Tennessee's Prescription for Success initiative, which brought together multiple state agencies under the Public Safety Subcabinet to develop a coordinated action plan. The plan focused on three key initiatives: reducing violent crime, addressing repeat offenders, and creating an environment for job growth. One outcome was a law requiring prescribers and dispensers to use the state's prescription drug monitoring program to curb doctor shopping and misuse. The initiative emphasizes cross-agency collaboration and using data to develop tailored community responses and mobilize resources to combat prescription drug abuse.
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
The document summarizes a Heroin Response Strategy presented by experts from various High Intensity Drug Trafficking Areas. The strategy involves 3 components: 1) Establishing a regional public health and public safety information sharing network through "Points of Light" teams in each state. 2) Implementing community education and prevention programs. 3) Creating a platform for regional public health and public safety partnerships through annual symposiums. The goal is to reduce drug overdoses through enhanced collaboration between law enforcement and health agencies.
Pitch Your Pills - Environmental Issues associated with prescription drug dis...
Pitch Your Pills overview at Florida Department of Environmental Protection for METRA, May 8, 2013. Learn more at seminolepreventioncoalition.org/pitchyourpills Presentation addressed the environmental issues associated with prescription drug disposal and providing an overview of Pitch Your Pills as a model campaign to implement permanent prescription drug disposal boxes. Led by William Morgan
Prescription drugs first do no harm update
This document discusses issues related to prescription drug abuse in First Nations, remote, rural, and isolated communities in Canada. It provides context on the organizations presenting, CCSA and NNAPF, and their visions of reducing substance-related harm. Key issues discussed include high prescription rates of opioids in First Nations communities, lack of treatment options, impacts of neonatal abstinence syndrome, risks of blood-borne diseases from injection drug use, and increased violence and crime. Community-based, culturally-relevant programs that provide greater access to opioid replacement therapies like suboxone are presented as potential strategies to address some of these issues.
Rx16 len tues_200_1_beshear_2ohr-menendez
This document summarizes a presentation on state and federal responses to the opioid epidemic. It discusses innovations from the Kentucky Attorney General including legislative measures targeting pill mills and heroin, programs to expand treatment and recovery, and education initiatives. It also describes the federal response through the Organized Crime Drug Enforcement Task Force (OCDETF), including their national heroin initiative targeting criminal organizations trafficking illegal opioids and heroin, and partnerships with other agencies to address public health and public safety aspects of the epidemic. The presentation outlines strategies at both state and federal levels aimed at improving access to treatment while also enforcing penalties on dealers through investigation and prosecution efforts.
Kyle molina harm reduction midterm project unm crp 275 community change in a ...
Currently our country is experiencing a national health crisis of opiate use and opiate related overdoses, with the corona virus causing these problems to only get worse. In 2019 the number of drug overdoses in the United States rose by 4.6% , for a total of 70,980, with 50,042 involving opioids (American Hospital Association, 2020)
It is estimated around 130 people die each day due to overdose and since 2010 a total of 400,000 deaths have occurred (DrugAbuse.Gov)
Following national trends New Mexico has seen an increase in reported overdoses since the early 2000s and in 2018 63.0% of drug overdose deaths involved opioids with a total of more than 338 fatalities.(DrugAbuse.Gov)
Transmission of bloodborne diseases such as HIV and Hepatitis C is also an issue among the population who use intravenously.
More Related Content
Viewers also liked
Tue vs ameritox -yasko-brasika_de_george
This document discusses the history and current state of medical marijuana in the United States. It provides background on marijuana's medical use in the early 20th century and subsequent criminalization. Today, over half of Americans support legalization and 21 states have legalized medical marijuana, though it remains illegal at the federal level. The document outlines administration methods, potential medical benefits seen with certain conditions, and the need for more robust research studies. It also discusses the conflict between state and federal law on marijuana and analyzes trends in marijuana use and perceived risk among the public.
Tue vs ondcp spitznas
Tuesday Vision Session: Office of National Drug Control Policy (ONDCP): Solutions Discussion Impacting Neonatal Abstinence Syndrome
Leonard Young CORRECT
This document summarizes a study evaluating the impact of unsolicited reports on prescription drug use. The study compared individuals who received unsolicited reports about questionable prescription patterns to a matched comparison group. It found reductions in several measures of questionable drug use were greater for the unsolicited report group compared to the comparison group, including a statistically significant decline in number of pharmacies visited. However, limitations included difficulty finding a suitable comparison group and incomplete prescription records. Possible next steps proposed expanding the study to address limitations.
Peter Kreiner
The document summarizes research analyzing associations between opioid overdose rates and rates of questionable prescription activity in Massachusetts communities. Key findings include:
1. Rates of opioid overdoses were positively associated with population density, poverty rates, and rates of questionable prescription activity in communities after controlling for other socioeconomic factors.
2. Rates of questionable prescription activity predicted subsequent increases in opioid overdose rates in communities over time, even after accounting for initial overdose rates and socioeconomic characteristics.
3. This research provides some of the first evidence that prescription drug monitoring program measures of questionable activity are useful indicators of geographic areas facing higher risks of opioid overdose.
Tue vs samhsa - harding
Tuesday Vision Session: Substance Abuse and Mental Health Services Administration (SAMHSA): Examining Prescription Drug Misuse and Abuse from Federal and National Perspectives
Tuesday astho
The document summarizes a vision session on prescription opioid overdose that included presentations from the Oklahoma Commissioner of Health and the president of ASTHO. Key points discussed include:
- The growing epidemic of prescription opioid overdose deaths and costs to the healthcare system.
- ASTHO's Prescription Drug Overdose Prevention Challenge which aims to reduce overdose rates and engages state health officials and partners across sectors.
- Strategies discussed to address the epidemic through prevention, monitoring, enforcement, treatment and recovery efforts.
Tue vs centpatico - van tassell
This document discusses trauma and its impacts on children in foster care. It provides an overview of PTSD and high rates of PTSD among children in foster care due to abuse, neglect, and family dysfunction. It also discusses the overuse of psychotropic medications in foster care and the need for trauma-informed treatment. Non-pharmacological interventions like TF-CBT are effective for treating trauma in children. Trauma-informed approaches are also needed within the criminal justice system given high rates of trauma among justice-involved individuals.
Tue gs mc cance-katz
This document discusses the importance of treatment for opioid use disorders. It notes the rise in prescription pain medication abuse and related harms like overdoses. Treatment options like medication-assisted treatment with drugs like methadone and buprenorphine combined with counseling can effectively treat opioid addiction, improving health and social outcomes. The Substance Abuse and Mental Health Services Administration promotes such evidence-based treatment approaches and prevention efforts to address the prescription drug abuse epidemic.
Tue gs botticelli
This document summarizes the national perspective on prescription drug abuse in the United States. It outlines the federal government's Prescription Drug Abuse Prevention Plan, which takes a coordinated approach across four focus areas: education, prescription drug monitoring programs, proper medication disposal, and enforcement. The document also provides some statistics showing signs of progress in reducing prescription drug abuse, such as decreases in the number of Americans initiating nonmedical use of prescription opioids and in the rates of past year use among high school seniors of certain opioids. However, it notes that long-term success will require ongoing coordination across government levels.
Ph 4 rannizzisi
The document discusses the growing problem of prescription drug abuse and overdose deaths in the United States. Some key points made include:
- In 2010, there were over 38,000 drug overdose deaths in the US, with prescription drugs accounting for over 22,000 of those deaths.
- Prescription drug abuse is the fastest growing drug problem in the country.
- Deaths from drug overdoses now outnumber deaths from motor vehicle accidents.
- The number of forensic drug cases tested has increased over 240% from 2001 to 2011.
- States in the Southwest and Appalachia have the highest rates of drug overdose mortality.
Tue gs collins
This document summarizes NIH efforts to advance pain relief while curbing opioid abuse. It discusses research on abuse-deterrent drug formulations, easier-to-use naloxone delivery methods, digital interventions to prevent overdose, and vaccine development to treat addiction. Monitoring the Future study results on nonmedical prescription opioid and heroin use among youth are presented. The director highlights collaborative work on an oral oxycodone prodrug and a promising heroin vaccine in development.
Viewers also liked (11)
Similar to Tuesday partnership
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
This document outlines an advocacy track presentation on activating communities to address prescription drug abuse. It provides biographies of the presenters and moderators and discloses any conflicts of interest. The learning objectives are to identify best practices for implementing CADCA's seven strategies for community change to impact prescription drug issues. It then provides examples of how various coalitions across the country are utilizing each of the seven strategies, such as providing education, enhancing skills, supporting communities, and changing policies.
Be aware, take action: fight counterfeits, keep patients safer
The document summarizes initiatives to combat counterfeit medicines in various countries. It finds that healthcare professionals' roles are often unclear and they are not always at the forefront of counterfeiting issues. The WHPA campaign aims to strengthen advocacy for investing in healthcare professionals' education and capacity to detect, report, and prevent counterfeits. It establishes dialogue between stakeholders to share knowledge and resources and initiate cost-effective solutions. The WHPA Call to Action and toolkit provide strategies and resources to build comprehensive regional plans against counterfeiting through increasing professional capacity, regional cooperation, collaborative practice, and improved collaboration with authorities.
Rx16 heroin wed_330_1_rader_2lynch-earle
This document summarizes presentations from two communities - Huntington, WV and Camden County, NJ - on their responses to heroin crises. It outlines programs implemented in Huntington, including a harm reduction program, centralized information system, and drug court expansion. It also discusses the region's history with prescription drug abuse and rise in heroin and associated issues like hepatitis and neonatal abstinence syndrome. Long-term strategies proposed include expanding treatment services, promoting career opportunities for those in recovery, and preventing relapse through environmental design changes.
Rx16 advocacy wed_200_1_mendell_2manlove
This document provides information about an advocacy track presentation on advocating for change related to addiction issues. The presentation features Gary Mendell, founder and CEO of Shatterproof, and Kim Manlove from the Indiana Addictions Issues Coalition. They will discuss strategies for influencing legislation and how people in recovery can become advocates. The learning objectives focus on advocating for state laws on PDMP usage, explaining strategies to influence legislation, describing how people in recovery can advocate, and providing counsel as part of a treatment team. The presentation then provides details on Shatterproof's story, the overdose epidemic, solutions for different populations, and legislative accomplishments in various states related to expanding access to naloxone and mandating PDMP usage.
Moving Beyond Stigma
The William James College Forum, "Moving Beyond Stigma," took place on May 23, 2017 at the Back Bay Events Center, Boston. The all-day event drew over 450 attendees: policymakers, business men/women, clinicians, and families.
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
The document summarizes a presentation on collaboration, coordination, and data to address prescription drug abuse at the state level. It discusses Tennessee's Prescription for Success initiative, which brought together multiple state agencies under the Public Safety Subcabinet to develop a coordinated action plan. The plan focused on three key initiatives: reducing violent crime, addressing repeat offenders, and creating an environment for job growth. One outcome was a law requiring prescribers and dispensers to use the state's prescription drug monitoring program to curb doctor shopping and misuse. The initiative emphasizes cross-agency collaboration and using data to develop tailored community responses and mobilize resources to combat prescription drug abuse.
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
The document summarizes a Heroin Response Strategy presented by experts from various High Intensity Drug Trafficking Areas. The strategy involves 3 components: 1) Establishing a regional public health and public safety information sharing network through "Points of Light" teams in each state. 2) Implementing community education and prevention programs. 3) Creating a platform for regional public health and public safety partnerships through annual symposiums. The goal is to reduce drug overdoses through enhanced collaboration between law enforcement and health agencies.
Pitch Your Pills - Environmental Issues associated with prescription drug dis...
Pitch Your Pills overview at Florida Department of Environmental Protection for METRA, May 8, 2013. Learn more at seminolepreventioncoalition.org/pitchyourpills Presentation addressed the environmental issues associated with prescription drug disposal and providing an overview of Pitch Your Pills as a model campaign to implement permanent prescription drug disposal boxes. Led by William Morgan
Prescription drugs first do no harm update
This document discusses issues related to prescription drug abuse in First Nations, remote, rural, and isolated communities in Canada. It provides context on the organizations presenting, CCSA and NNAPF, and their visions of reducing substance-related harm. Key issues discussed include high prescription rates of opioids in First Nations communities, lack of treatment options, impacts of neonatal abstinence syndrome, risks of blood-borne diseases from injection drug use, and increased violence and crime. Community-based, culturally-relevant programs that provide greater access to opioid replacement therapies like suboxone are presented as potential strategies to address some of these issues.
Rx16 len tues_200_1_beshear_2ohr-menendez
This document summarizes a presentation on state and federal responses to the opioid epidemic. It discusses innovations from the Kentucky Attorney General including legislative measures targeting pill mills and heroin, programs to expand treatment and recovery, and education initiatives. It also describes the federal response through the Organized Crime Drug Enforcement Task Force (OCDETF), including their national heroin initiative targeting criminal organizations trafficking illegal opioids and heroin, and partnerships with other agencies to address public health and public safety aspects of the epidemic. The presentation outlines strategies at both state and federal levels aimed at improving access to treatment while also enforcing penalties on dealers through investigation and prosecution efforts.
Kyle molina harm reduction midterm project unm crp 275 community change in a ...
Currently our country is experiencing a national health crisis of opiate use and opiate related overdoses, with the corona virus causing these problems to only get worse. In 2019 the number of drug overdoses in the United States rose by 4.6% , for a total of 70,980, with 50,042 involving opioids (American Hospital Association, 2020)
It is estimated around 130 people die each day due to overdose and since 2010 a total of 400,000 deaths have occurred (DrugAbuse.Gov)
Following national trends New Mexico has seen an increase in reported overdoses since the early 2000s and in 2018 63.0% of drug overdose deaths involved opioids with a total of more than 338 fatalities.(DrugAbuse.Gov)
Transmission of bloodborne diseases such as HIV and Hepatitis C is also an issue among the population who use intravenously.
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
The panel discussed two youth prevention programs - the Give Me a Reason voluntary drug testing program for parents and the This Is (Not) about Drugs prevention program implemented in schools. The Give Me a Reason program provides free at-home drug testing kits for parents to help prevent drug use among youth. The This Is (Not) about Drugs program uses a film and lesson plan to educate students about the risks of prescription opioid and heroin use with the goal of preventing first-time drug use.
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
This document outlines a presentation on state initiatives impacting physicians and patients related to controlled substances. It includes disclosures from presenters and planners, as well as learning objectives. The first presentation discusses Maryland's emergency preparedness plan for responding when a physician's license to prescribe controlled substances is suspended. The plan was developed after an incident where over 2,000 patients lost access to prescriptions. It involves coordinating state agencies, conducting surveys, developing response teams, and temporarily providing resources to mitigate public health impacts. Focus groups provided guidance on barriers, triaging patients, documenting for referrals, and estimating costs. The goal is to deploy temporary resources at the local level until normal care processes resume.
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
The document outlines state responses to prescription drug and heroin abuse presented at an advocacy track session. It includes presentations from officials in Arizona, Virginia, and New Mexico on their state's strategies. Arizona's presentation focuses on the state's prescriber report cards. Virginia's presentation discusses the governor's task force recommendations and a new health and criminal justice data committee. New Mexico's presentation describes the state's high overdose rates and model of stakeholder collaboration to reduce overdose deaths.
Rx15 treat tues_1115_1_seppala_2kosterman-warren
This document summarizes presentations on the evolution of diagnosis and treatment options for substance use disorders. It discusses how Hazelden integrated medication-assisted treatment with the Minnesota Model approach. Recent brain science breakthroughs allow for improved diagnosis of chronic pain and addiction through quantitative electroencephalography (qEEG) brain mapping. Combining evidence-based medical and behavioral treatments with neurorestorative brain treatments shows potential for improved outcomes.
Tx 2 joint presentation
Treatment: Barriers to Access to Care - American Society of Addiction Medicine's Advancing Access to Addiction Medications Initiative
Welfare and Drug Testing Policy in the USA
American Congress adopted the Anti Drug Abuse Act in 1988. In 1995 the policy was further refined and the government started implementing its drug free policy. The drug free policy enforce denial of federal benefits to users, possessors and traffickers from one to five years and the third timers permanently. This included grants, contracts, licensing, loans, but excluded welfare and public housing. In 1996 the government enacted Personal Responsibility and Work Opportunity Reconciliation Act, created Temporary Assistance for Needy Families (TANF) to make people move from welfare to work, a mandatory state run drug test.
Lauren Angel
Lauren's Angels is a nonprofit organization based in Winsted, Connecticut that focuses on substance abuse prevention and awareness through community outreach events and school presentations. They serve adolescents and young adults in northwest Connecticut. The organization uses an open systems theory approach and is influenced by external factors like drug availability and economic issues. Key roles include substance abuse counselors, a community outreach coordinator, and speakers. The proposed annual budget is $25,000 which will cover office space, utilities, supplies, and advertising while staying within nonprofit spending guidelines. The organization will track outcomes through surveys, interviews and document reviews to evaluate their progress in decreasing overdoses and increasing the number of individuals served.
L ang.pptx
Lauren's Angels is a nonprofit organization based in Winsted, Connecticut that focuses on substance abuse prevention and awareness through community outreach events and school presentations. They serve adolescents and young adults in northwest Connecticut. The organization uses an open systems theory approach and is influenced by external factors like drug availability and economic issues. Key roles include substance abuse counselors, a community outreach coordinator, and speakers. The proposed annual budget is $25,000 which will cover office space, utilities, supplies, and advertising while staying within nonprofit spending guidelines. The organization will track data, conduct surveys and interviews, and use qualitative methods to evaluate outcomes and success stories.
Advocacy – Mental Health Issues
Powerpoint strongly draws on material from WHO RESOURCE BOOK ON MENTAL HEALTH -
HUMAN RIGHTS AND LEGISLATION -Stop exclusion, dare to care - WHO 2005
Similar to Tuesday partnership (20)
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Be aware, take action: fight counterfeits, keep patients safer
Be aware, take action: fight counterfeits, keep patients safer
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Pitch Your Pills - Environmental Issues associated with prescription drug dis...
Pitch Your Pills - Environmental Issues associated with prescription drug dis...
Kyle molina harm reduction midterm project unm crp 275 community change in a ...
Kyle molina harm reduction midterm project unm crp 275 community change in a ...
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
Rx16 adv tues_200_1_wright_2orr_3landen_4hartstebbins
More from OPUNITE
Dr. Tom Frieden keynote
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
Dr. Francis Collins keynote
Dr. Francis Collins, Director of the National Institutes of Health, keynote address at the National Rx Drug Abuse & Heroin Summit on March 29, 2016.
Kana Enomoto keynote
Kana Enomoto, Acting Administrator, Substance Abuse and Mental Health Services Administration, keynote presentation at the National Rx Drug Abuse & Heroin Summit March 29, 2016
Rx16 claad tue-vision_final
Addiction Is A Disease, Not A Choice, And Should Be Treated As Such - updated to correct error 4-11-16
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
This document summarizes a presentation on managing morphine equivalent dose (MED) and identifying high-risk opioid use through "red flagging." It discusses how calculating MED at the point of sale can help identify unsafe dosages and decrease opioid prescriptions. It also evaluates different methods to screen for overdose risk, finding that simple opioid use thresholds to flag patients may not accurately target those most likely to experience preventable overdoses. The presentation aims to explain MED management, describe payer solutions that reduced opioid use, and identify more precise ways to intervene with highest-risk patients.
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
This document discusses the role of health departments in preventing neonatal abstinence syndrome (NAS). It notes that NAS rates have increased significantly in recent years, disproportionately affecting women. Health departments engage in surveillance to monitor NAS trends, partner with other organizations, support treatment and recovery programs, and provide education to prevent NAS, which is entirely preventable. The document outlines specific strategies health departments use across these areas to address the opioid epidemic and protect maternal and infant health.
Rx16 general session_wed_800_1_volkow copy
The document discusses the opioid crisis in the United States, including rising rates of prescription opioid misuse and abuse, as well as heroin use and overdose deaths. It outlines how research can help address this crisis through developing less abusable analgesics, expanding access to treatment medications like naloxone and buprenorphine, and exploring new treatment approaches such as immunotherapies and precision medicine targeting genetic factors. The National Institute on Drug Abuse is supporting these research efforts and working to disseminate findings to improve prevention and intervention programs.
Rx16 general session_900_1_botticelli
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
This presentation covered multi-media prevention strategies for issues like prescription drug overdoses. It discussed the CDC's digital Rx drug prevention campaign, best practices for digital messaging, and programs using expectancy challenge theory and media literacy education in schools. Presenters included representatives from the CDC, Media Literacy for Prevention, and the Hanley Center Foundation who discussed their work developing and implementing digital communications and single-session prevention programs.
Rx16 treat wed_330_1_barnes_2clarkolsen
This document discusses strategies for reducing buprenorphine diversion and pill mills while improving access to treatment. It notes that limiting access to buprenorphine treatment is associated with increased diversion, while expanded access to quality treatment decreases diversion and overdose deaths. The document recommends educating prescribers, using medically-derived prescribing standards, ensuring adequate insurance coverage of safe prescribing practices, and addressing diversion risks for other controlled medications. It argues against onerous new regulations that could limit treatment access. The goal is to identify and support high-quality treatment while prosecuting criminal operations.
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
This document summarizes a presentation on linking and mapping prescription drug monitoring program (PDMP) data. It discusses the benefits of linking PDMP data to clinical data, including improving patient safety, evaluating prescribing decisions, and assessing the impact of PDMP interventions. It describes challenges with linking data, such as obtaining consent and negotiating data use agreements. It also discusses Washington State's MAPPING OPIOID AND OTHER DRUG ISSUES (MOODI) tool, which integrates PDMP data with other databases to map and target treatment and overdose prevention efforts at the community level.
Rx16 prev wed_330_workplace issues and strategies
This document discusses workplace issues related to prescription drug abuse and strategies for prevention. It begins with introductions of the presenters and moderators. The learning objectives are then outlined as understanding challenges of prescription drug abuse in the workplace, identifying prevention strategies, and describing programs available through SAMHSA. The document then covers topics such as the scope of prescription drug misuse among workers, risks to the workplace, prevention strategies employers can consider, and available resources from SAMHSA.
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
This document discusses a presentation on pharmacy burglary, robbery, and diversion of prescription drugs. The presentation covers trends in prescription drug diversion, particularly those involving robbery and burglary of pharmacies. It identifies preventative measures to enhance pharmacy security and safety. Strategies to reduce pharmacy crimes are outlined. The offender perspective is examined based on interviews with convicted offenders. Routine activities theory is discussed as relating to suitable targets, capable guardians, and motivated offenders. Partnerships between regulatory agencies and law enforcement are emphasized as key to prevention efforts.
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Linking and mapping PDMP data can provide several benefits but also faces challenges. Linking PDMP and clinical data allows for evaluating the impact of PDMP interventions on outcomes and prescribing decisions. However, obtaining permissions and data is difficult due to legal and resource barriers. Mapping PDMP data using GIS tools in Washington identified areas for targeting overdose prevention efforts by visualizing patterns in prescribing risks, treatment availability, and overdoses. Stakeholders used these maps to guide education and funding decisions. Sustaining these tools requires ongoing funding and expanding included data sources.
Rx16 len wed_330_1_ferdinand_2price
This document discusses drug court models and the role of law enforcement in drug courts. It begins with introductions from presenters and outlines learning objectives about explaining drug court operations and benefits, how law enforcement can utilize drug courts, and identifying best practices. The following sections provide details on drug court models, including how they integrate treatment into the justice system using a non-adversarial approach. Key components of drug courts are outlined, and presenters discuss issues like prescription drug and heroin abuse as well as outcomes from drug courts in reducing recidivism and saving money. Law enforcement can play roles in prevention, addressing domestic violence, and targeting the right populations for drug court involvement through assessment.
Rx16 clinical wed_330_1_saunders_2wexelblatt
This document discusses neonatal abstinence syndrome (NAS) and universal maternal drug testing. It provides background information on NAS including trends showing large increases in incidence and costs associated with NAS. It outlines objectives related to describing NAS trends, identifying legislative activities impacting NAS, describing family planning for women in substance abuse treatment, and explaining a hospital program using universal drug testing. The document then covers topics including NAS symptoms, incidence and geographic trends, costs of NAS, opioid use in women of childbearing age, unintended pregnancy rates, contraceptive use among opioid users, and maternal drug exposure sources.
Rx16 treat wed_200_group_falkinburg_miller
This document discusses recovery ready ecosystems and recovery community organizations. It introduces presenters from Young People in Recovery and Hope House Treatment Track who will discuss interventions, prevention, and recovery programs. Examples of Young People in Recovery chapters, programs, and services are provided, including employment workshops, education workshops, housing workshops, and recovery support services. The document also discusses recovery community organizations and initiatives in Texas and Georgia, such as the Association of Persons Affected by Addiction in Dallas and the Georgia Council on Substance Abuse.
Rx16 tpp wed_200_group
This document summarizes a presentation on health plan involvement in safe prescribing. It includes:
1) Presentations from medical experts on prescription drug abuse trends from medical examiner data and a tribal health system's safe prescribing program.
2) A discussion of health plan policies to reduce "red flag" medication combinations like opioids plus benzodiazepines through prior authorization, formulary changes, and provider restrictions.
3) Examples of one health plan's implementation of policies like restricting methadone prescriptions to pain specialists and removing carisoprodol from its formulary.
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
This document summarizes a presentation on youth performance-enhancing drugs and ADHD medication. It discusses trends in misuse of these substances among young people. The presentation is given by representatives from various organizations focused on prevention, health promotion, and substance abuse issues among youth and college students. The presentation covers types of performance-enhancing drugs and their potential side effects. It also discusses trends in attitudes towards these substances and risks of misuse. Strategies are presented for helping adolescents pursue their goals without these drugs. The document concludes by outlining plans for addressing misuse of ADHD medication among college students through education and collaboration between various stakeholder groups.
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Community pharmacists are well positioned to help address the growing problem of opioid and benzodiazepine addiction but face challenges. Early identification of at-risk patients, supportive benefit structures, and intervention training could empower pharmacists. While many recognize their responsibility, behavioral engagement in prevention is often lacking due to practice barriers, lack of patient information, and fear of responses. Standardizing communication expectations and screening tools could help pharmacists better fulfill their role on the treatment team.
More from OPUNITE (20)
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Recently uploaded
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Ketone bodies and metabolism-biochemistry
This slide consists of all the topics of ketone . This can be used for exam purpose for writing about Diabetic keto acidosis etc . Thank you
Journal Article Review on Rasamanikya
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
All info about Diabetes and how to control it.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
This quiz was conducted as a promotional event for the 2024 Annual Meet of Kerala Chapter of API.
More than 20 participants took part everyday !
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
This document outlines policies and procedures for handling narcotic and controlled drugs in NABH accredited hospitals.
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Recently uploaded (20)
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Tuesday partnership
- 1. Marcia Lee Taylor April 22, 2014 Atlanta, Georgia
- 2. 2011 White House Report • Called for major national effort to educate parents, youth, and patients about the dangers of abusing prescription drugs, as well as prescriber education • Major Challenge: No dedicated funding • Opportunity: Create a coalition of private sector entities with a stake in the problem as well as federal and non-profit partners who can join together to create a large scale, multi-target education effort
- 3. One Solution: The Medicine Abuse Project A 5-year awareness, education and action campaign that is: • Addressing all categories of medicine abuse (pain medication, stimulants, tranquilizers and sedatives, Rx cough, and OTC cough) because all are part of the same consumer behavior of intentional medicine abuse • Enlisting all major organizations with a stake – and an important role to play – in preventing medicine abuse to join in a concerted effort and national call to action • Empowering key sectors to take action and mobilize their constituencies • Encouraging all participants to showcase their work on medicine abuse prevention and join with others to also deliver two key messages: – Clean out your medicine cabinets/secure your medication – Talk to your kids about medicine abuse
- 4. The Medicine Abuse Project • Objective: Reduce by 500,000 the number of teens initiating medicine abuse over the next five years – Promote parent-child discussion of the risks of medicine abuse – Promote safeguarding and proper disposal of medicine at home – Identify action steps for key stakeholders: prescribers, dispensers, educators, communities, law enforcement • “Take the Pledge” at www.medicineabuseproject.org to do your part
- 5. Strategic Partners 8 FEDERAL PARTNERS • Office of National Drug Control Policy • Drug Enforcement Administration • National Institute on Drug Abuse • Bureau of Justice Assistance • Centers for Disease Control and Prevention • Food and Drug Administration • U.S. Attorneys • Substance Abuse and Mental Health Services Administration 80+ NATIONAL & STATE PARTNERS • National and local grassroots orgs: i.e. Emergency Room MDs, Nat. Assn. of Boards of Pharmacy, National Education Association, National Association of School Nurses, American Academy of Family Physicians, ADA, and many more…
- 7. 7
- 15. The Medicine Abuse Project: Local Event • Local organizations can hold their own screenings of the Out of Reach documentary as a conversation starter in their community • 20 minute documentary followed by panel discussion about teen Rx abuse where you live, what is being done to address it and what more can be done • Event can be open to the press • The Partnership can help provide technical assistance with potential panelists – school nurses, ER doctors, elected officials, etc. • Toolkit includes moderator’s guide, handouts, audience evaluation forms, model media advisory and sample press release
- 16. The Medicine Abuse Project: Local Event To obtain a copy of the “Out of Reach” documentary as well as a link to the online toolkit, email: communications@drugfree.org